Delivery Order SPE2DB22D1106-SPE2DB25FFFD7
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,470.05 on August 28, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement executed under the company's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30 count) with a ceiling value of $3,506.24. This competitive delivery order, which employs firm fixed price contracting, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order carries no set-aside designation and is...
- The Defense Logistics Agency awarded a $35,627.20 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Clomid 50 mg tablets in unit dose packs of 30 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 22, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $3,513.70 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30s) on September 12, 2025, with an ultimate completion date of September 15, 2025. The contract utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30 tablets. This competitively awarded, non-set-aside contract carries a ceiling value of $9,458.24 under firm fixed price terms, with an ultimate completion date of July 24, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Clomid 50 mg tablets in unit dose packages of 30 units, with a contract ceiling value of $1,207.41. This competitively awarded, non-set-aside delivery order has a firm fixed price structure and an ultimate completion date of August 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count) with a ceiling value of $1,224.98. The contract, awarded on September 19, 2025, is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count) with a ceiling value of $3,474.96. This competitively awarded, non-set-aside contract has a firm fixed price structure and an ultimate completion date of August 18, 2025. The delivery order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,492.20 for Clomid 50 mg tablets (30-count unit dose packaging) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, non-set-aside contract operates under firm fixed pricing and represents a child order issued against AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's headquarters location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Clomid 50 mg tablets in unit dose packages of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $22,176.29 under a firm fixed price arrangement, with completion scheduled for September 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFFD7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count), with a ceiling value of $7,314.66. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and the Defense Health Agency. The company's contract portfolio with DLA demonstrates its established capability to deliver both brand-name and generic pharmaceuticals across multiple therapeutic domains, positioning it as a key vendor within the federal medical supply chain supporting defense and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 8/25/25 |